Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · September 01, 2023

Benefit and Safety of Switching to Insulin Glargine 300 U/mL as Basal Insulin for Inpatient Glycaemic Control

Journal of Diabetes and its Complications

 

Additional Info

Journal of Diabetes and its Complications
Clinical impact after implementing an insulin protocol involving a switch to insulin glargine 300 U/ml as basal insulin for inpatient glycaemic control: A retrospective single-centre study
J Diabetes Complicat 2023 Aug 09;37(9)108584, P Repetto, D Ayago

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading